Logo image of AMRC

AMERESCO INC-CL A (AMRC) Stock Fundamental Analysis

NYSE:AMRC - New York Stock Exchange, Inc. - US02361E1082 - Common Stock - Currency: USD

18.12  -0.66 (-3.51%)

After market: 18.12 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMRC. AMRC was compared to 49 industry peers in the Construction & Engineering industry. Both the profitability and financial health of AMRC have multiple concerns. AMRC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AMRC had positive earnings in the past year.
In the past year AMRC had a positive cash flow from operations.
AMRC had positive earnings in each of the past 5 years.
AMRC had negative operating cash flow in 4 of the past 5 years.
AMRC Yearly Net Income VS EBIT VS OCF VS FCFAMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

AMRC has a Return On Assets of 1.30%. This is comparable to the rest of the industry: AMRC outperforms 42.86% of its industry peers.
Looking at the Return On Equity, with a value of 5.35%, AMRC is in line with its industry, outperforming 48.98% of the companies in the same industry.
The Return On Invested Capital of AMRC (2.07%) is worse than 65.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AMRC is significantly below the industry average of 16.67%.
Industry RankSector Rank
ROA 1.3%
ROE 5.35%
ROIC 2.07%
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
AMRC Yearly ROA, ROE, ROICAMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 2.97%, AMRC perfoms like the industry average, outperforming 53.06% of the companies in the same industry.
AMRC's Profit Margin has declined in the last couple of years.
AMRC's Operating Margin of 4.84% is in line compared to the rest of the industry. AMRC outperforms 48.98% of its industry peers.
In the last couple of years the Operating Margin of AMRC has declined.
Looking at the Gross Margin, with a value of 14.31%, AMRC is in line with its industry, outperforming 40.82% of the companies in the same industry.
In the last couple of years the Gross Margin of AMRC has declined.
Industry RankSector Rank
OM 4.84%
PM (TTM) 2.97%
GM 14.31%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
AMRC Yearly Profit, Operating, Gross MarginsAMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMRC is destroying value.
Compared to 1 year ago, AMRC has more shares outstanding
AMRC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AMRC has been reduced compared to a year ago.
AMRC Yearly Shares OutstandingAMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMRC Yearly Total Debt VS Total AssetsAMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.04, we must say that AMRC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.04, AMRC is doing worse than 71.43% of the companies in the same industry.
AMRC has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.55, AMRC is not doing good in the industry: 67.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACC0.22
WACC9.53%
AMRC Yearly LT Debt VS Equity VS FCFAMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

AMRC has a Current Ratio of 1.57. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC has a Current ratio of 1.57. This is in the better half of the industry: AMRC outperforms 77.55% of its industry peers.
A Quick Ratio of 1.56 indicates that AMRC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.56, AMRC belongs to the top of the industry, outperforming 81.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.56
AMRC Yearly Current Assets VS Current LiabilitesAMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The earnings per share for AMRC have decreased strongly by -10.53% in the last year.
Measured over the past 5 years, AMRC shows a small growth in Earnings Per Share. The EPS has been growing by 3.47% on average per year.
AMRC shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.13%.
AMRC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.34% yearly.
EPS 1Y (TTM)-10.53%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%0%
Revenue 1Y (TTM)30.13%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%18.24%

3.2 Future

Based on estimates for the next years, AMRC will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.33% on average per year.
AMRC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next Y-23.2%
EPS Next 2Y4.72%
EPS Next 3Y17.49%
EPS Next 5Y16.33%
Revenue Next Year7.13%
Revenue Next 2Y8.45%
Revenue Next 3Y9.51%
Revenue Next 5Y8.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMRC Yearly Revenue VS EstimatesAMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AMRC Yearly EPS VS EstimatesAMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.76, the valuation of AMRC can be described as rather expensive.
91.84% of the companies in the same industry are more expensive than AMRC, based on the Price/Earnings ratio.
AMRC is valuated rather cheaply when we compare the Price/Earnings ratio to 28.05, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.20, AMRC is valued correctly.
Based on the Price/Forward Earnings ratio, AMRC is valued cheaper than 85.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.67. AMRC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.76
Fwd PE 16.2
AMRC Price Earnings VS Forward Price EarningsAMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMRC indicates a somewhat cheap valuation: AMRC is cheaper than 71.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.23
AMRC Per share dataAMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

AMRC's earnings are expected to grow with 17.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)5.12
EPS Next 2Y4.72%
EPS Next 3Y17.49%

0

5. Dividend

5.1 Amount

No dividends for AMRC!.
Industry RankSector Rank
Dividend Yield N/A

AMERESCO INC-CL A

NYSE:AMRC (7/25/2025, 8:04:00 PM)

After market: 18.12 0 (0%)

18.12

-0.66 (-3.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners93.66%
Inst Owner Change-1.05%
Ins Owners7.71%
Ins Owner Change10.96%
Market Cap953.11M
Analysts75.29
Price Target21.65 (19.48%)
Short Float %9.17%
Short Ratio5.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.04%
Min EPS beat(2)-8.27%
Max EPS beat(2)64.35%
EPS beat(4)1
Avg EPS beat(4)-10.47%
Min EPS beat(4)-66.19%
Max EPS beat(4)64.35%
EPS beat(8)3
Avg EPS beat(8)-4.78%
EPS beat(12)5
Avg EPS beat(12)-1.18%
EPS beat(16)9
Avg EPS beat(16)4.47%
Revenue beat(2)1
Avg Revenue beat(2)6.22%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)12.84%
Revenue beat(4)3
Avg Revenue beat(4)6.79%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)13.75%
Revenue beat(8)6
Avg Revenue beat(8)5.69%
Revenue beat(12)9
Avg Revenue beat(12)4.87%
Revenue beat(16)11
Avg Revenue beat(16)3.9%
PT rev (1m)2.69%
PT rev (3m)-3.54%
EPS NQ rev (1m)-21.05%
EPS NQ rev (3m)-75%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)0.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 17.76
Fwd PE 16.2
P/S 0.52
P/FCF N/A
P/OCF 13.92
P/B 0.94
P/tB 1.02
EV/EBITDA 14.23
EPS(TTM)1.02
EY5.63%
EPS(NY)1.12
Fwd EY6.17%
FCF(TTM)-7.16
FCFYN/A
OCF(TTM)1.3
OCFY7.18%
SpS34.68
BVpS19.24
TBVpS17.76
PEG (NY)N/A
PEG (5Y)5.12
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 5.35%
ROCE 2.62%
ROIC 2.07%
ROICexc 2.11%
ROICexgc 2.17%
OM 4.84%
PM (TTM) 2.97%
GM 14.31%
FCFM N/A
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
ROICexc(3y)3.29%
ROICexc(5y)3.76%
ROICexgc(3y)3.41%
ROICexgc(5y)3.91%
ROCE(3y)3.99%
ROCE(5y)4.56%
ROICexcg growth 3Y-23.67%
ROICexcg growth 5Y-13.36%
ROICexc growth 3Y-23.08%
ROICexc growth 5Y-12.71%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Debt/EBITDA 8.58
Cap/Depr 471.74%
Cap/Sales 24.39%
Interest Coverage 0.84
Cash Conversion 37.49%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.56
Altman-Z 1.04
F-Score6
WACC9.53%
ROIC/WACC0.22
Cap/Depr(3y)645.79%
Cap/Depr(5y)553.31%
Cap/Sales(3y)27.71%
Cap/Sales(5y)23.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%0%
EPS Next Y-23.2%
EPS Next 2Y4.72%
EPS Next 3Y17.49%
EPS Next 5Y16.33%
Revenue 1Y (TTM)30.13%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%18.24%
Revenue Next Year7.13%
Revenue Next 2Y8.45%
Revenue Next 3Y9.51%
Revenue Next 5Y8.47%
EBIT growth 1Y6.36%
EBIT growth 3Y-5.42%
EBIT growth 5Y9.79%
EBIT Next Year90.63%
EBIT Next 3Y37.6%
EBIT Next 5Y27.24%
FCF growth 1Y-2.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2114.03%
OCF growth 3YN/A
OCF growth 5YN/A